4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-020566
Director sold 11,000 shares at $3.37 ($37,096)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dorval Allison Director | 2024-06-13 | Sale 10b5-1 | −11,000 | $3.37 | $37,096 | 33,000 | D |
| Open-market sales · 11,000 sh · avg $3.37 · $37,096 | |||||||
Loading xslF345X05/rdgdoc.xml…